Latest AI and machine learning research in alzheimer's disease for healthcare professionals.
BACKGROUND: Alzheimer's disease (AD) is the most frequent cause of dementia among the elderly. The accumulation of amyloid beta (Aβ) and its downstream pathological events such as oxidative stress play central roles in AD. Recent studies revealed that Aβ oligomer (AβO)-induced strong neurotoxicity in SH-SY5Y cells via the induction of oxidative stress.
This study was to explore the application of MRI based on artificial intelligence technology combined with neuropsychological assessment to the cognitive impairment of patients with neurological cerebrovascular diseases. A total of 176 patients were divided into a control group, a vascular cognitive impairment non-dementia (VCIND) group, a vascular dementia (VD) group, and an Alzheimer's disease (...
Alzheimer's disease (AD) is a neurodegenerative disease involving the decline of cognitive ability with illness progresses. At present, the diagnosis ...
Impairment of navigation is one of the earliest symptoms of Alzheimer's disease (AD), but to date studies have involved proxy tests of navigation rath...
Fully automated and volumetric segmentation of critical tumors may play a crucial role in diagnosis and surgical planning. One of the most challenging...
Specific brain structures (gray matter regions and white matter tracts) play a dominant role in determining cognitive decline and explain the heteroge...
For now, Alzheimer's disease (AD) is incurable. But if it can be diagnosed early, the correct treatment can be used to delay the disease. Most of the ...
Remote health monitoring can help prevent disease at the earlier stages. The Internet of Things (IoT) concepts have recently advanced, enabling omnipr...
Alzheimer's Disease (AD) is a progressive, neurodegenerative brain disease and is an incurable ailment. No drug exists for AD, but its progression can...
Identifying the molecular systems and proteins that modify the progression of Alzheimer's disease and related dementias (ADRD) is central to drug targ...
The majority of clinical trials fail due to low efficacy of investigated drugs, often resulting from a poor choice of target protein. Existing computa...
Genetic algorithms have a proven capability to explore a large space of solutions, and deal with very large numbers of input features. We hypothesized...
Although deep networks have been shown to perform very well on a variety of medical imaging tasks, inference in the presence of pathology presents sev...
BACKGROUND AND PURPOSE: Diagnostic-quality amyloid PET images can be created with deep learning using actual ultra-low-dose PET images and simultaneou...
Five fluorescent positively charged poly(-aryleneethynylene) (-) were designed to construct electrostatic complexes - with negatively charged graphene...
Assistive technology (AT) with context-aware computing and artificial intelligence capabilities can be applied to address cognitive and communication ...
Alzheimer's disease (AD) is the leading cause of age-related dementia, affecting over 5 million people in the United States and incurring a substantia...
Alzheimer's disease (AD) is the most generally known neurodegenerative disorder, leading to a steady deterioration in cognitive ability. Deep learning...
PURPOSE: To compare two artificial intelligence software packages performing normative brain volumetry and explore whether they could differently impa...
Initial development of artificial Intelligence (AI) and machine learning (ML) dates back to the mid-twentieth century. A growing awareness of the pote...